Impact Of FDA Advisory Cmte. Conflict Rules Extends To OTC Side
Executive Summary
New Nonprescription Drugs Advisory Committee member James Kehrer's expertise in acetaminophen toxicity should make him a key figure at FDA's upcoming meeting on the drug, he says
You may also be interested in...
Nissen, Califf Absent From Prasugrel Panel
The prominent cardiologists – and FDA commissioner candidates – had separate conflicts that prohibited their participation.
Advisory Committee Policy Allows Members With Financial Conflicts To Vote
FDA advisory committee participants with personal financial conflicts of interest may fully participate in committee meetings, according to the agency's new conflict of interest policy. The final guidance eliminates the draft provision that financial conflicts of any sort preclude an opportunity for panelists to vote
J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.